Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions

EMBO Journal

Volumn 17, Issue 22, 1998, Pages 6558-6572

  Kalus, Wenzel ^a   Zweckstetter, Markus ^a   Renner, Christian ^a   Sanchez, Yolanda ^a   Georgescu, Julia ^a   Grol, Michael ^b   Demuth, Dirk ^b   Schumacher, Ralf ^b   Dony, Carola ^b   Lang, Kurt ^b   Holak, Tad A ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

IGF binding; IGF receptor binding; IGF receptor structure; IGFBP 5; Insulin like growth factor

Indexed keywords

ALANINE; ISOLEUCINE; LEUCINE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 5; VALINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BETA CHAIN; BONE TISSUE; ESCHERICHIA COLI; EXPRESSION VECTOR; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE;

ANIMALIA; ESCHERICHIA COLI;

EID: 0032538802     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.22.6558     Document Type: Article

References (82)

1. Andress, D.L., Loop, S.M., Zapf, J. and Kiefer, M.C. (1993) Carboxytruncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem. Biophys. Res. Commun., 195, 25-30.
2. Arai, T., Clarke, J., Parker, A., Busby, W., Jr, Nam, T. and Clemmons, D.R. (1996) Substitution of specific amino acids in insulin-like growth factor (IGF) binding protein 5 alters heparin binding and its change in affinity for IGF-I response to heparin. J. Biol. Chem., 271, 6099-6106.
3. Bach, L.A., Hsieh, S., Sakano, K., Fujiwara, H., Perdue, J.F. and Rechler, M.M. (1993) Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. J. Biol. Chem., 268, 9246-9254.
4. Bautista, C.M. Baylink, D.J. and Mohan, S. (1991) Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone. Biochem. Biophys. Res. Commun., 176, 756-763.
5. Bax, A. and Grzesiek, S. (1993) Methodological advances on protein. Acc. Chem. Res., 26, 131-138.
6. Bax, A., Vuister, G.W., Grzesiek, S., Delaglio, F., Wang, A.C., Tschudin, R. and Zhu, G. (1994) Measurement of homonuclear and heteronuclear J-couplings from quantitative J-correlation. Methods Enzymol., 239, 79-105.
7. Braunschweiler, L. and Ernst, R.R. (1983) Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy. J. Magn. Reson., 53, 521-528.
8. Brown, L.R., and Farmer, B.T. (1989) Rotating frame nuclear Overhauser effect. Methods Enzymol., 176, 199-216.
9. Brünger, A.T. (1993) X-PLOR Version 3.1 Manual. Yale University, New Haven, CT.
10. Brünger, A. and Nilges, M. (1993) Computational challenges for macromolecular structure determinations by X-ray crystallography and solution NMR. Q. Rev. Biophys., 26, 49-125.
11. Campbell, P.G. and Andress, D.L. (1997) Insulin-like growth facor (IGF)-binding protein-5-(201-218) region regulates hydroxyapatite and IGF-I binding. Am. J. Physiol. Endocrinol Metabol., 36, 1005-1013.
12. Chemausek, S.D., Smith, C.E., Duffin, K.L., Busby, W.H., Wright, G. and Clemmons, D.R. (1995) Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4. J. Biol. Chem., 270, 11377-11382.
13. Cieslar, C., Ross, A., Zink, T. and Holak, T.A. (1993) Efficiency in multidimensional NMR by optimized recording of time point-phase pairs in evolution periods and their selective linear transformation. J. Magn. Reson., 101, 97-101.
14. Clemmons, D.R. (1993) IGF binding proteins and their functions. Mol. Repr. Dev., 35, 368-375.
15. Clemmons, D.R. (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev., 8, 45-62.
16. Conover, C.A. (1995) Insulin-like growth factor binding protein proteolysis in bone cell models. Prog. Growth Factor Res., 6, 301-309.
17. Cooke, R.M., Harvey, T.S. and Campbell, I.D. (1991) Solution structure of human insulin-like growth factor 1: a nuclear magnetic resonance and restrained molecular dynamics study. Biochemistry, 30, 5484-5491.
18. Craik, D.J. and Wilce, J.A. (1997) Studies of protein-ligand interactions by NMR. Methods Mol. Biol., 60, 195-232.
19. Dhalluin, C., Wieruszeski, J.M. and Lippens, G. (1996) An improved hononuclear tocsy experiment with minimal water saturation. J. Magn. Reson., 111, 168-170.
20. Durham, S.K., Mohan, S., Liu, F. Baker, B.K., Lee, P.D., Hintz, R.L., Conover, C.A. and Powell, D.R. (1997) Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum. Pediatr. Res., 42, 335-341.
21. Edison, A.S., Abildgaard, F., Westler, W.M., Mooberry, E.S. and Markley, J.L. (1994) Practical introduction to theory and implementation of multinuclear, multidimensional nuclear magnetic resonance experiments. Methods Enzymol., 239, 3-79.
22. 15N NMR relaxation. Biochemistry, 33, 5984-6003.
23. 13C-double-filtered NOESY with strongly reduced artifacts and improved sensitivity. J. Biomol. NMR, 5, 427-432.
24. Fowlkes, J.L., Serra, D.M. Rosenberg, C.K. and Thrailkill, K.M. (1995) Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J. Biol. Chem., 270, 27481-27488.
25. Francis, G.L., Aplin, S.E., Milner, S.J., McNeil, K.A., Ballard, F.J. and Wallace, J.C. (1993) Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. Biochem. J., 293, 713-719.
26. Gill, R. et al. (1996) Engineering the C-region of human insuline-like growth factor-1. Implications for receptor binding. Protein Eng., 9. 1011-1019.
27. Gill, Z.P. Perks, C.M., Newcomb, P.V. and Holly, J.M. (1997) Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner. J. Biol. Chem., 272, 25602-25607.
28. Grzesiek, S. and Bax, A. (1992a) Correlating backbone amide and side-chain resonances in larger proteins by multiple relayed triple resonance NMR. J. Am. Chem. Soc., 114, 6291-6293.
29. Grzesiek, S. and Bax, A. (1992b) Improved 3D triple-resonance NMR techniques applied to a 31 kDa protein. J. Magn. Reson., 96, 432-440.
30. Hashimoto, R., Ono, M., Fujiwara, H., Higashihashi, N., Yoshida, M., Enjohkimura, T. and Sakano, K. (1997) Binding sites and binding properties of binary and ternary complexes of Insulin-Like Growth Factor-II (IGF-II), IGF-binding protein-3 and acid-labile subunit. J. Biol. Chem., 272, 27936-27942.
31. Heding, A., Gill, R., Ogawa, Y., De Meyts, P. and Shymko, R.M. (1996) Biosensor measurement of the binding of insulin-like growth factors I and II and their analogues to the insulin-like growth factor-binding proteins. J. Biol. Chem., 271, 13948-13952.
32. Higo, H., Duan, C. Clemmons, D.R. and Herman, B. (1997) Retionic acid inhibits cell growth in HPV negative cervical carcinoma cells by induction of insulin-like growth factor binding protein-5 (IGFBP-5) secretion. Biochem. Biophys. Res. Commun., 239, 706-709.
33. Ho, M.N., Delgado, C.H., Owens, G.A. and Steller, M.A. (1997) Insulin-like growth factor-II participates in the biphasic effect of a gonadotropin-releasing hormone agonist on ovarian cancer cell growth. Fertil. Steril., 67, 870-876.
34. Hobba, G.D., Forbes, B.E., Parkinson, E.J., Francis, G.L. and Wallace, J.C. (1996) The insulin-like growth factor (IGF) binding site of bovine insulin-like growth factor binding protein-2 (bIGFBP-2) probed by iodination. J. Biol Chem., 271, 30529-30536.
35. Hoffman, D.W. and Spicer, L.D. (1991) Isotopic labeling of specific amino acid types as an aid to NMR spectrum assignment of the methionine repressor protein. In Villafranca, J.J. (ed.) Techniques in Protein Chemistry II, Academic Press, San Diego, CA, pp. 409-419.
36. Holak, T.A., Gondol, D., Otlewski, J. and Wilusz, T. (1989) Determination of the complete three-dimensional structure of the trypsin inhibitor from squash seeds in aqueous solution by nuclear magnetic resonance and a combination of distance geometry and dynamical simulated annealing. J. Mol. Biol. 210, 635-648.
37. 13C J-couplings between carbonyl and carbonyl/carboxyl carbons in isotopically enriched proteins. J. Am. Chem. Soc., 118, 8170-8171.
38. 3J (NC)γ couplings in isotopically enriched proteins. J. Biomol. NMR, 9, 323-328.
39. 13C 3-bond J-couplings measured by 3-dimensional heteronuclear NMR - how planar is the peptide-bond. J. Am. Chem. Soc., 119, 6360-6368.
40. 1 angles of aromatic residues in proteins from 3-bond J (C'C-γ) and J (NC-γ) couplings. J. Am. Chem. Soc., 119, 1803-1804.
41. Hull, E.W. (1994) Experimental aspects of two-dimensional NMR. In Croasmun, W.R and Carlson, R.M.K. (eds) Two-Dimensional NMR-Spectroscopy, 2nd edn, VCH, Weihneim, pp. 67-437.
42. Insight II User Guide (1995) Biosym/MSI, San Diego, CA.
43. Jahnke, W., Baur, M., Gemmecker, G. and Kessler, H. (1995) Improved accuracy of NMR structures by a modified NOESY-HSQC experiment. J. Magn. Reson., 106, 86-88.
44. Jansson, M., Uhlen, M. and Nilsson, B. (1997) Structural changes in insulin-like growth factor IGF I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor. Biochemistry. 36, 4108-1117.
45. Jones, J.I., Gockerman, A., Bushy, W.H., Jr., Camacho-Hubner, C. and Clemmons, D.R. (1993) Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I. J. Cell Biol., 121, 679-687.
46. 2O samples of proteins. J. Magn. Reson., 101, 333-337.
47. Kiefer, M.C., Schmid, C., Waldvogel, M., Schlapfer, I., Futo, E., Masiarz, F.R., Green, K., Barr, P.J. and Zapf, J. (1992) Characterization of recombinant human insulin-like growth factor binding proteins 4, 5 and 6 produced in yeast. J. Biol. Chem., 267, 12692-12699.
48. Klaus, W., Broger, C., Gerber, P. and Senn, H. (1993) Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data. Application to flavoridin. J. Mol. Biol., 232, 897-906.
49. Koradi, R., Billeter, M. and Wüthrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph., 14, 51-55.
50. Kupce, E. and Freeman, R. (1995) Stretched adiabatic pulses for broadband spin inversion. J. Magn. Reson., 117, 246-256.
51. Lippens, G., Dhalluin, C. and Wieruszeski, J.M. (1995) NOE spectroscopy, water suppression and water flip-back. Use of a water flip-back pulse in the homonuclear NOESY experiment. J. Biomol. NMR, 5, 327-331.
52. Loddick, S.A. et al. (1998) Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke. Proc. Natl Acad. Sci. USA, 95, 1894-1898.
53. 2NCO-E.COSY, a simple method for the stereospecific assignment of side-chain amide protons in proteins. J. Magn. Reson., 124, 255-258.
54. Luthi, C., Roth, B.V. and Humbel, R.E. (1992) Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants. Eur. J. Biochem., 205, 483-190.
55. Marion, D., Ikura, M., Tschudin, R. and Bax, A. (1989) Rapid recording of 2D NMR-spectra without phase cycling-application to the study of hydrogen-exchange in proteins. J. Magn. Reson., 85, 393-399.
56. Mohans, S., Nakao, Y., Honda, Y., Landale, E., Leser, U., Dony, C., Lang, K. and Baylink, D.J. (1995) Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J. Biol. Chem., 270, 20424-20431.
57. Mori, S., Abeygunawardana, C., Johnson, M.O. and Vanzijl, P.C.M. (1995) Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J. Magn. Reson., 108, 94-98.
58. Muchmore, D.C., McIntosh, L.P., Russell, C.B., Anderson, D.E. and Dahlquist, F.W. (1989) Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. Methods Enzymol., 177, 44-73.
59. 1H-NMR spectroscopy: combined use with isotope labelling for studies of macromolecular conformation and intramolecular interactions. Q. Rev. Biophys., 23, 39-96.
60. Qin, X., Strong, D.D., Baylink, D.J. and Mohan, S.J (1998) Structure-function analysis of the human insulin-like growth factor binding protein-4. J. Biol. Chem., 273, 23509-23516.
61. Rajaram, S., Baylink, D.J. and Mohan, S. (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids. Endocrinol. Rev., 18, 801-831.
62. 1H-NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun., 117, 479-185.
63. Rosen, C.J. et al. (1997) Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone, 21, 217-223.
64. Shaka, A.J., Lee, C.J. and Pines, A. (1988) Iterative schemes for bilinear operators - application to spin decoupling. J. Magn. Reson., 77, 274-293.
65. Silver, M.S., Joseph, R.I. and Hoult, D.I. (1984) Highly selective π/2 and π pulse eeneration. J. Magn. Reson. 59, 347-351.
66. 15N HSQC experiments optimized to retain full sensitivity. J. Magn. Reson. 102, 241-245.
67. Sommer, A., Spratt, S.K., Tatsuno, G.P., Tressel, T., Lee, R. and Maack, C.A. (1993) Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3). Growth Regul., 3, 46-19.
68. Spencer, E.M. and Chan, K. (1995) A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs): supporting evidence using the structural determinants of the IGF binding site on IGFBP-3. Prog. Growth Factor Res. 6, 209-214.
69. Stewart, C.E. and Rotwein, P. (1996) Growth, differentiation and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev., 76, 1005-1026.
70. Stonehouse, J., Clowes, R.T., Shaw, G.L., Keeler, J. and Laue, E.D. (1995) Minimization of sensitivity losses due to the use of gradient pulses in triple-resonance NMR of proteins. J. Biomol. NMR, 5, 226-232.
71. Talluri, S. and Wagner, G. (1996) An optimized 3D NOESY-HSQC. J. Magn. Reson., 112, 200-205.
72. Terasawa, H., Kohda, D., Hatanaka, H., Nagata, K., Higashihashi, N., Fujiwara, H., Sakano, K. and Inagaki, F. (1994) Solution structure of human insulin-like growth factor II: recognition sites for receptors and binding proteins. EMBO J., 13, 5590-5597.
73. Torres, A.M., Forbes, B.E., Aplin, S.E., Wallace, J.C., Francis, G.L. and Norton, R.S. (1995) Solution structure of human insulin-like growth factor II. Relationship to receptor and binding protein interactions. J. Mol. Biol., 248, 385-401.
74. 15N-enriched proteins. J. Am. Chem. Soc., 115, 7772-7777.
75. Walsh, G. (1995) Nervous excitement over neuotrophic factors. Biotechnology 13, 1167-1171.
76. Wang, J.F., Hampton, B., Mehlman, T., Burgess, W.H. and Rechler, M.M. (1988) Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors. Biochem. Biophys. Res. Commun., 157, 718-726.
77. Werner, H. and LeRoth, D. (1998) The role of the insulin-like growth factor system in human cancer. Adv. Cancer Res., 68, 183-223.
78. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids. John Wiley, New York, NY.
79. Yeh, L.C., Adamo, M.L., Olson, M.S. and Lee, J.C. (1997) Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology, 138, 4181-4190.
80. Zapf, J., Kiefer, M., Merryweather, J., Musiarz, F. Bauer, D., Born, W., Fischer, J.A. and Froesch, E.R. (1990) Isolation from adult human serum of four insulin-like growth factor (IGF) binding proteins and molecular cloning of one of them that is increased by IGF I administration and in extrapancreatic tumor hypoglycemia J. Biol. Chem., 265, 14892-14898.
81. Zhang, O. and Forman-Kay, J.D. (1995) Structural characterization of folded and unfolded states of an SH3 domain in equilibrium in aqueous buffer. Biochemistry, 34, 6784-6794.
82. Zwahlen, C., Legault, P, Vincent, S.J.F., Greenblatt, J., Konrat, R. and Kay, L.E. (1997) Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy - application to a bacteriophage lambda N-peptide/box RNA complex. J. Am. Chem. Soc., 119, 6711-6721.